The SITC Forward Fund is pleased to announce the recipients of 2022 SITC Fellowships to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of impactful research.
The 2022 SITC Fellowships recipients are:
SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship
Award Amount: $200,000 (two-year)
Recipient: Simone Minnie, PhD
Institution: Fred Hutchinson Cancer Research Center
Project Title: “Harnessing Treg fragility to improve anti-myeloma immune responses”
SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship
Award Amount: $100,000 (one-year)
Recipient: John Ligon, MD
Institution: University of Florida
Project Title: “Leveraging CD70 CXCR2-modified CAR T-cells for treating AML”
SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship
Award Amount: $100,000 (one-year)
Recipient: Jonathan Chen, MD, PhD
Institution: Massachusetts General Hospital
Project Title: “Dissecting the tumor immunity multicellular network”
SITC-Merck Cancer Immunotherapy Clinical Fellowship
Award Amount: $100,000 (one-year)
Awardee: Hitomi Hosoya, MD, PhD
Institution: Stanford University
Project Title: “Cell-free DNA-based Platform to Determine Treatment Response and Resistant Mechanisms to CAR T-cell Therapy in Multiple Myeloma"
SITC-Genentech Women in Cancer Immunotherapy Fellowship
Award Amount: $50,000 (one-year)
Recipient: Shu-chin Lai, PhD
Institution: Huntsman Cancer Institute, University of Utah
Project Title: “Augmenting T cell immunity to facilitate metastatic breast cancer treatment”
SITC-Nektar Therapeutics Equity and Inclusion in Cancer Immunotherapy Fellowship
Award Amount: $50,000 (one-year)
Recipient: Mara De Martino, PhD
Institution: Weill Cornell Medicine
Project Title: “Targeting FASN to sensitize irradiated glioblastoma to immunotherapy”
SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
Award Amount: $40,000 (one-year)
Recipient: Steven Blum, MD
Institution: Dana-Farber Cancer Institute, Massachusetts General Hospital
Project Title: “Distinguishing Immune-Related Adverse Events (irAEs) from Anti-Tumor Immunity”
SITC-Natera ctDNA in Immunotherapy Response Monitoring Fellowship and Technology Award
Award: $40,000 and access to Natera’s Signatera™ testing technology
Recipient:Mariya Rozenblit, MD
Institution:Yale University
Project Title: “The tumor microenvironment of triple negative breast cancers with detectable circulating tumor DNA after pembrolizumab treatment”
SITC-NanoString Technologies Single Cell Biology Award
Award: Access to NanoString Technologies’ CosMx™ Spatial Molecular Imager (SMI)
Recipient: Elshad Hasanov, MD, PhD
Institution: University of Texas MD Anderson Cancer Center
Project Title: “CosMxing renal cell carcinoma brain metastases to decipher immune checkpoint inhibitor resistance mechanisms at single-cell and spatial context”
2022 NCI Immunotherapy Fellowship
Award: This one-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono.
Awardee: Elisabetta Xue, MD
Institution: San Raffaele Hospital
2022 NCI Immunotherapy Fellowship
Award: This one-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono.
Awardee: Alexander Rankin, MD
Institution: Children's Hospital Colorado, University of Colorado School of Medicine
2022-24 NCI Immunotherapy Fellowship
Award: This one-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono.
Awardee: Dara Bracken-Clarke, BMed, BCh, BAO
Institution: Waterford University Hospital, Ireland
The 2022 SITC Fellowships were made possible through the generosity of Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Genentech, Mallinckrodt Pharmaceuticals, Merck, Nektar Therapeutics, NanoString Technologies and Natera Technologies.